Bifogade filer
PDF
Kurs
-5,23%
Kalender
| Est. tid* | ||
| 2025-02-28 | - | Bokslutskommuniké 2024 |
| 2024-10-31 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-29 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-18 | - | Årsstämma |
| 2024-05-16 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-29 | - | Bokslutskommuniké 2023 |
| 2023-11-13 | - | Extra Bolagsstämma 2023 |
| 2023-10-19 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-04 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2023-05-03 | - | Årsstämma |
| 2023-04-26 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-23 | - | Bokslutskommuniké 2022 |
| 2022-10-21 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-04 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2022-05-03 | - | Årsstämma |
| 2022-04-26 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-24 | - | Bokslutskommuniké 2021 |
| 2021-12-22 | - | Extra Bolagsstämma 2021 |
| 2021-10-20 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-16 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-04 | - | X-dag ordinarie utdelning ELOS B 1.50 SEK |
| 2021-05-03 | - | Årsstämma |
| 2021-04-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-24 | - | Bokslutskommuniké 2020 |
| 2020-10-20 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-16 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-05 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-22 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2020-04-21 | - | Årsstämma |
| 2020-02-18 | - | Bokslutskommuniké 2019 |
| 2019-10-24 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-18 | - | Kvartalsrapport 2019-Q2 |
| 2019-04-24 | - | X-dag ordinarie utdelning ELOS B 1.00 SEK |
| 2019-04-23 | - | Årsstämma |
| 2019-04-23 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-18 | - | Bokslutskommuniké 2018 |
| 2018-10-25 | - | Kvartalsrapport 2018-Q3 |
| 2018-07-19 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-25 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2018-04-24 | - | Årsstämma |
| 2018-04-24 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-19 | - | Bokslutskommuniké 2017 |
| 2017-10-24 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-27 | - | X-dag ordinarie utdelning ELOS B 1.30 SEK |
| 2017-04-26 | - | Årsstämma |
| 2017-04-26 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-24 | - | Bokslutskommuniké 2016 |
| 2016-10-26 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-24 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-27 | - | X-dag ordinarie utdelning ELOS B 1.00 SEK |
| 2016-04-26 | - | Årsstämma |
| 2016-04-26 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-25 | - | Bokslutskommuniké 2015 |
| 2015-10-23 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-21 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-28 | - | X-dag bonusutdelning ELOS B 1 |
| 2015-04-28 | - | X-dag ordinarie utdelning ELOS B 2.00 SEK |
| 2015-04-27 | - | Årsstämma |
| 2015-04-27 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-19 | - | Bokslutskommuniké 2014 |
| 2014-10-24 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-22 | - | Kvartalsrapport 2014-Q2 |
| 2014-04-30 | - | X-dag ordinarie utdelning ELOS B 2.00 SEK |
| 2014-04-29 | - | Årsstämma |
| 2014-04-29 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-21 | - | Bokslutskommuniké 2013 |
| 2013-10-23 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-21 | - | Kvartalsrapport 2013-Q2 |
| 2013-04-26 | - | X-dag ordinarie utdelning ELOS B 1.00 SEK |
| 2013-04-25 | - | Årsstämma |
| 2013-04-25 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-22 | - | Bokslutskommuniké 2012 |
| 2012-10-26 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-22 | - | Kvartalsrapport 2012-Q2 |
| 2012-04-24 | - | X-dag ordinarie utdelning ELOS B 1.50 SEK |
| 2012-04-23 | - | Årsstämma |
| 2012-04-23 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-24 | - | Bokslutskommuniké 2011 |
| 2011-10-26 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-18 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-04 | - | X-dag ordinarie utdelning ELOS B 1.50 SEK |
| 2011-05-03 | - | Årsstämma |
| 2011-05-03 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-25 | - | Bokslutskommuniké 2010 |
| 2010-10-27 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-19 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-29 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2010-04-28 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-25 | - | Bokslutskommuniké 2009 |
| 2009-10-23 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-20 | - | Kvartalsrapport 2009-Q2 |
| 2009-04-30 | - | X-dag ordinarie utdelning ELOS B 1.50 SEK |
| 2009-04-29 | - | Årsstämma |
| 2009-04-29 | - | Kvartalsrapport 2009-Q1 |
| 2008-04-29 | - | X-dag ordinarie utdelning ELOS B 1.50 SEK |
| 2007-04-26 | - | X-dag ordinarie utdelning ELOS B 0.50 SEK |
| 2006-04-28 | - | X-dag ordinarie utdelning ELOS B 1.25 SEK |
| 2005-05-20 | - | Split ELOS B 1:2 |
| 2005-05-04 | - | X-dag ordinarie utdelning ELOS B 2.50 SEK |
| 2004-04-30 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2003-05-07 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2002-04-26 | - | X-dag ordinarie utdelning ELOS B 0.00 SEK |
| 2001-04-27 | - | X-dag ordinarie utdelning ELOS B 2.25 SEK |
| 1995-06-15 | - | Split ELOS B 1:2 |
Beskrivning
| Land | Sverige |
|---|---|
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Elos Medtech AB's Board has today appointed the Chairman of the Board Stefano Alfonsi as new President and CEO as of September 5, 2022. In connection with this, Stefano will step down as Chairman of the Board but remain a Board Member. The Board has appointed the current Board Member Magnus René as new Chairman of the Board as of September 5, 2022. Stefano succeeds Jodie Gilmore and Søren Olesen who will remain in their positions as President & Business Unit Directors. The changes in the Board and Management are subject to approval by the Swedish Companies Registration Office.
Stefano has extensive experience from the medical technology industry where he has held positions as Chairman of the Board of Directors and CEO of Corin Group PLC, CEO of Lima Corporate SpA and Vice President positions in Johnson & Johnson DePuy.
Stefano Alfonsi says: "I am honored to be associated with Elos Medtech, initially as Chairman of the Board and now as CEO. Elos Medtech is on the path to strongly develop and enhance its leading position on the medical device market. Each employee at Elos Medtech across Asia, Europe and USA, are passionate and determined to exceed our customers' expectations and I am proud to now become their CEO. I want to thank our Board for the trust showed in me, and Jodie and Søren for their leadership during this transition. I am looking forward to the future journey, continuing to grow this global medical technology company."
Magnus René, Chairman of the Board of Elos Medtech says: "We are very pleased that Stefano takes the position as the company's new CEO. Stefano's extensive experience makes him perfectly suited to lead the company in its next phase."
About Elos Medtech
Elos Medtech is a leading development and production partner for medical devices and components, with a focus on dental and orthopedic implants and instruments. The company operates from facilities in Sweden, Denmark, China, and the U.S. The customer base comprises international medical technology companies.
Elos Medtech has more than 600 employees and a turnover of more than SEK 750 million. Elos Medtech has been listed on NASDAQ Stockholm AB since 1989. Elos Medtech's B share is categorized as a Health Care company on the Mid Cap list.
Gothenburg, September 5, 2022
Elos Medtech AB (publ)
For further information, please contact:
Lovisa Lander, Board Member, +44 (0)20 7823 0211, e-post: llander@ta.com
For additional information about the Elos Medtech Group, visit www.elosmedtech.com
This is information that Elos Medtech AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above on September 5, 2022, at 14:30 (CET).